S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Cancer
Interventions: DRUG: dasatinib
Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)